All In MedTech

Device Trial Radar · NCT06571370

Wave Crossover ECP Study for Simplified Therapy

Last checked: Nov 19, 2026Latest source record: Apr 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

52

Actual

Start

Sep 26, 2024

Primary completion

Feb 4, 2025

Study completion Feb 4, 2025

Sponsor

Lead sponsor
PressionNot on our public-company list
Sponsor type
Industry
First posted
Aug 26, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 35 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate substantial equivalence between Pression's Wave PRO System and a commercially available predicate ECP device to support a U.S. 510(k) submission for the Wave PRO System.

Conditions

  • Chronic Stable Angina
  • Refractory Angina

Interventions

  • External CounterpulsationDevice

    Cardiac gated, lower limb compression

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diastolic AugmentationTime frame: During treatment, measured at the 8th minute of compressions

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Monroe Biomedical Research

    Monroe, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.